Myopia control glasses.

Optical design matters

Editors #PunktZwrotny2050 Sources checked: 09.09.2026 How to read this data

What is this method?

The glasses correct the focus, and the selected designs tested additionally modify the distribution of the optical stimulus in order to slow down the growth of the eye. Not every lens described as "myopic" is a progression control lens.

Mechanism and idea

DIMS and aspherical microlens designs create a defined defocus distribution outside the clear vision area. Design differences are part of the intervention, not just the trade name.

How has the evidence developed?

The history includes earlier multifocal approaches and the more recent DIMS and HAL /SAL studies. The registry shows each construct and its control group separately.

Go to full timeline

Key randomized trials

2020RCTHong Kong

Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial

In the DIMS RCT, the average axis extension over the 2 years was 0,21 mm compared to 0,55 mm with single vision lenses.

Study of the specific design of DIMS ; 160 children completed follow-up. Online 2019, volume of 2020 magazine. It does not prove that all defocus glasses work.

Publication, Authors and Restrictions
2022RCTChina

Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial

Testing of spectacle lenses with aspherical microlenses showed inhibition of progression for the HAL design compared to single vision lenses.

Product and design-dependent result; is not a direct comparison of HAL with DIMS.

Publication, Authors and Restrictions

Evidence reviews and syntheses

The review is not a substitute for checking a specific intervention. The publication date and query end date may vary.

2025 Review/Consensus Global

IMI-Interventions for Controlling Myopia Onset and Progression 2025

IMI 2025 organizes optical, pharmacological, environmental and lighting strategies and the state of research on their effects.

Mature technologies and emerging methods have a different evidence base. The inspection is not an individual clinical eligibility assessment of the child.

Publication, Authors and Restrictions

What do longer observations tell us?

The two-year RCT DIMS and HAL is a clearly defined follow-up period. Longer extensions may add additional information, but group switching and participant loss limit comparison with the baseline RCT.

Safety

The rating includes sharpness, image tolerance, fit and way of wearing. Good results from one design do not guarantee identical comfort and effect from another.

Limitations and open questions

We do not rank DIMS versus HAL from two separate RCTs. Age, baseline defect, control group, and wear time may vary between works.

  • Which design elements are responsible for the effect?
  • How does the result depend on wear time and fit?
  • How does progression behave when changing structures?

When is it considered?

They are one of the optical options considered for children with progression. The choice of design requires an assessment of the defect, binocular vision, tolerance and real wearability.

What should be monitored?

  • Refraction, acuity and axis length
  • Centration, frame and actual wear time
  • Visual comfort and possible progression despite wearing

This is a framework for a conversation with a specialist, not an individual treatment plan.

References for this chapter

2021Guidelines/consensusEurope

Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute

ESO and IMI present a framework for the selection of management, prevention and monitoring of myopia progression.

The guidelines require reference to current knowledge, local availability and the specific patient.

Publication, Authors and Restrictions

Availability

Text size
100%
Contrast
Reading
SOURCE RECORD

Source record